CORT compared with OMER: revenue, margins and what each company keeps, and the suppliers and customers both name

CORTCorcept Therapeutics Inc

Mkt capRevenueRevenue

OMEROmeros Corp

Mkt capRevenueRevenue

Compare

CORTCorcept Therapeutics Inc

OMEROmeros Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CORT1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+27.29%—

OMER

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.3%▲+26.55%×2.16

May 14 '26±10.6%▼−7.65%×0.73

= impliedCORT realized, solidOMER realized, hatchedOne scale, both sides: full bar = 28%× = |realized| ÷ impliedSource: market data

Q1 FY26

±15.9%

▲+14.39%

×0.91

Jan 8 '26±15.0%▼−4.54%×0.30

CORTCorcept Therapeutics Inc

81.11· pre 81.51

Mkt cap$8.8BRevenue$256MQ2 FY26Revenue$761MFY25

OMEROmeros Corp

18.46· pre 18.71· delayed

Pre-marketSep 2 '83

Mkt cap$1.3BRevenue$29MQ2 FY26Revenue—

Compare

Pre-marketSep 2 '83

CORTCorcept Therapeutics Inc

OMEROmeros Corp

81.11pre 81.51

Price

18.46pre 18.71delayed

$8.8B

Mkt cap

$1.3B

Q2 FY26$256M

Revenue

$29MQ2 FY26

FY25$761M

Revenue

—

CORT81.11vsOMER18.46Pre-marketSep 2 '83